Sopharma AD Statistics

Total Valuation

Sopharma AD has a market cap or net worth of PLN 2.05 billion. The enterprise value is 3.06 billion.

Market Cap	2.05B
Enterprise Value	3.06B

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	Nov 7, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+19.22%
Shares Change (QoQ)	-23.80%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	40.66M

Valuation Ratios

The trailing PE ratio is 12.00.

PE Ratio	12.00
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	1.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.94, with an EV/FCF ratio of 32.22.

EV / Earnings	17.90
EV / Sales	0.67
EV / EBITDA	8.94
EV / EBIT	13.97
EV / FCF	32.22

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.57.

Current Ratio	1.17
Quick Ratio	0.52
Debt / Equity	0.57
Debt / EBITDA	3.59
Debt / FCF	11.10
Interest Coverage	5.93

Financial Efficiency

Return on equity (ROE) is 10.28% and return on invested capital (ROIC) is 3.92%.

Return on Equity (ROE)	10.28%
Return on Assets (ROA)	2.88%
Return on Invested Capital (ROIC)	3.92%
Return on Capital Employed (ROCE)	7.10%
Revenue Per Employee	838,130
Profits Per Employee	30,496
Employee Count	5,599
Asset Turnover	1.29
Inventory Turnover	4.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.07% in the last 52 weeks. The beta is -0.04, so Sopharma AD's price volatility has been lower than the market average.

Beta (5Y)	-0.04
52-Week Price Change	-5.07%
50-Day Moving Average	12.79
200-Day Moving Average	13.04
Relative Strength Index (RSI)	55.69
Average Volume (20 Days)	102

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sopharma AD had revenue of PLN 4.69 billion and earned 170.75 million in profits. Earnings per share was 1.03.

Revenue	4.69B
Gross Profit	1.02B
Operating Income	167.31M
Pretax Income	200.61M
Net Income	170.75M
EBITDA	247.52M
EBIT	167.31M
Earnings Per Share (EPS)	1.03

Full Income Statement

Balance Sheet

The company has 79.12 million in cash and 1.05 billion in debt, giving a net cash position of -974.27 million.

Cash & Cash Equivalents	79.12M
Total Debt	1.05B
Net Cash	-974.27M
Net Cash Per Share	n/a
Equity (Book Value)	1.86B
Book Value Per Share	10.90
Working Capital	274.07M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 167.99 million and capital expenditures -73.13 million, giving a free cash flow of 94.87 million.

Operating Cash Flow	167.99M
Capital Expenditures	-73.13M
Free Cash Flow	94.87M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 21.71%, with operating and profit margins of 3.57% and 3.64%.

Gross Margin	21.71%
Operating Margin	3.57%
Pretax Margin	4.27%
Profit Margin	3.64%
EBITDA Margin	5.27%
EBIT Margin	3.57%
FCF Margin	2.02%

Dividends & Yields

This stock pays an annual dividend of 0.36, which amounts to a dividend yield of 2.77%.

Dividend Per Share	0.36
Dividend Yield	2.77%
Dividend Growth (YoY)	-89.19%
Years of Dividend Growth	n/a
Payout Ratio	216.37%
Buyback Yield	-19.22%
Shareholder Yield	-16.45%
Earnings Yield	8.33%
FCF Yield	4.63%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sopharma AD has an Altman Z-Score of 2.56. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.56
Piotroski F-Score	n/a